60
Participants
Start Date
January 23, 2023
Primary Completion Date
August 31, 2027
Study Completion Date
August 31, 2028
Ripasudil
Topical Ripasudil 0.4%
Placebo
Topical Placebo
RECRUITING
University of Pennsylvania, Philadelphia
RECRUITING
Wills Eye Hospital, Philadelphia
RECRUITING
University of Miami, Palm Beach Gardens
RECRUITING
Stanford University, Palo Alto
RECRUITING
University of California Davis, Sacramento
RECRUITING
Oregon Health & Science University, Portland
RECRUITING
Dartmouth-Hitchcock Medical Center, Lebanon
Oregon Health and Science University
OTHER
University of California, San Francisco
OTHER
University of California, Davis
OTHER
Case Western Reserve University
OTHER
Dartmouth-Hitchcock Medical Center
OTHER
University of Pennsylvania
OTHER
University of Miami
OTHER
Wills Eye Hospital
UNKNOWN
Stanford University
OTHER